Fresenius Medical Care (NYSE:FMS – Get Free Report) had its target price lifted by analysts at Truist Financial from $22.00 to $23.00 in a research note issued on Monday, Benzinga reports. The firm currently has a "hold" rating on the stock. Truist Financial's price target would indicate a…
